Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000:(2):CD000124.
doi: 10.1002/14651858.CD000124.

Lobeline for smoking cessation

Affiliations

Lobeline for smoking cessation

L F Stead et al. Cochrane Database Syst Rev. 2000.

Update in

  • Lobeline for smoking cessation.
    Stead LF, Hughes JR. Stead LF, et al. Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD000124. doi: 10.1002/14651858.CD000124.pub2. Cochrane Database Syst Rev. 2012. PMID: 22336780 Free PMC article.

Abstract

Background: Lobeline is a partial nicotine agonist, which has been used in a variety of commercially available preparations to help stop smoking.

Objectives: The objective of this review was to assess the effects of lobeline on long term smoking cessation.

Search strategy: We searched the Cochrane Tobacco Addiction Group trials register.

Selection criteria: Randomized trials comparing lobeline to placebo or an alternative therapeutic control, which reported smoking cessation with at least six months follow-up.

Data collection and analysis: We extracted data in duplicate on the type of subjects, the dose and form of lobeline, the outcome measures, method of randomisation, and completeness of follow-up.

Main results: We identified no trials meeting the full inclusion criteria including long term follow-up.

Reviewer's conclusions: There is no evidence available from long term trials that lobeline can aid smoking cessation.

PubMed Disclaimer

Publication types

LinkOut - more resources